Telix Pharmaceuticals Ltd
ASX:TLX
Telix Pharmaceuticals Ltd
ASX:TLX
Price:
15.05
AUD
1.69%
Market Closed
Market Cap:
AU$5.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
AU |
|
B
|
Booking Holdings Inc
F:PCE1
|
US |
|
P
|
Petsec Energy Ltd
ASX:PSA
|
AU |
|
Gear4music (Holdings) PLC
F:G4A
|
UK |
|
Marin Software Inc
NASDAQ:MRIN
|
US |
|
WT Microelectronics Co Ltd
TWSE:3036
|
TW |
|
Ohba Co Ltd
TSE:9765
|
JP |
|
T
|
Tenderhut SA
WSE:THG
|
PL |
|
Nordstrom Inc
NYSE:JWN
|
US |
|
PLC SpA
MIL:PLC
|
IT |
|
AGTech Holdings Ltd
HKEX:8279
|
HK |
|
H
|
Hunter Douglas NV
F:HUD
|
NL |
|
M
|
Megaron SA
WSE:MEG
|
PL |
|
R
|
Redington (India) Ltd
NSE:REDINGTON
|
IN |
|
Mitchells & Butlers PLC
LSE:MAB
|
UK |
|
A
|
Anzheng Fashion Group Co Ltd
SSE:603839
|
CN |
|
Cluey Ltd
ASX:CLU
|
AU |
|
Vardhman Acrylics Ltd
NSE:VARDHACRLC
|
IN |
|
Annehem Fastigheter AB (publ)
STO:ANNE B
|
SE |
|
Deutsche Real Estate AG
F:DRE2
|
DE |
|
PCBL Ltd
NSE:PCBL
|
IN |
|
China Communications Construction Co Ltd
HKEX:1800
|
CN |
Cash Flow Statement
Cash Flow Statement
Telix Pharmaceuticals Ltd
Telix Pharmaceuticals Ltd
Currency: AUD
| Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Stock-Based Compensation |
0
|
3
|
4
|
3
|
6
|
6
|
3
|
6
|
11
|
13
|
18
|
19
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
(2)
|
(8)
|
(10)
|
(11)
|
(3)
|
1
|
(21)
|
|
| Cash Interest Paid |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(3)
|
(9)
|
(14)
|
|
| Change in Working Capital |
9
|
11
|
11
|
12
|
31
|
12
|
1
|
(10)
|
(14)
|
(17)
|
(14)
|
(46)
|
|
| Cash from Operating Activities |
(27)
N/A
|
2
N/A
|
(8)
N/A
|
(59)
-622%
|
(91)
-53%
|
(41)
+54%
|
10
N/A
|
14
+50%
|
34
+138%
|
27
-19%
|
22
-20%
|
(17)
N/A
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(1)
|
(0)
|
(0)
|
(1)
|
(10)
|
(9)
|
(8)
|
(7)
|
(21)
|
(31)
|
(45)
|
(56)
|
|
| Other Items |
(0)
|
(1)
|
(1)
|
(1)
|
(3)
|
(2)
|
(1)
|
(10)
|
(32)
|
(56)
|
(270)
|
(230)
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
-9%
|
(1)
-12%
|
(3)
-123%
|
(13)
-387%
|
(11)
+17%
|
(9)
+22%
|
(17)
-97%
|
(53)
-215%
|
(87)
-63%
|
(315)
-264%
|
(286)
+9%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
46
|
35
|
36
|
4
|
182
|
117
|
5
|
4
|
4
|
1
|
1
|
2
|
|
| Net Issuance of Debt |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
1
|
4
|
3
|
3
|
426
|
421
|
(6)
|
|
| Other |
0
|
(0)
|
0
|
0
|
(8)
|
(5)
|
0
|
0
|
0
|
(10)
|
0
|
0
|
|
| Cash from Financing Activities |
44
N/A
|
34
-22%
|
34
0%
|
3
-92%
|
174
+6 003%
|
113
-35%
|
8
-93%
|
7
-16%
|
7
-3%
|
417
+5 934%
|
412
-1%
|
(4)
N/A
|
|
| Change in Cash | |||||||||||||
| Effect of Foreign Exchange Rates |
(2)
|
(2)
|
1
|
3
|
3
|
0
|
(0)
|
1
|
(2)
|
(2)
|
9
|
9
|
|
| Net Change in Cash |
14
N/A
|
33
+134%
|
25
-24%
|
(56)
N/A
|
73
N/A
|
61
-16%
|
9
-85%
|
6
-40%
|
(14)
N/A
|
356
N/A
|
128
-64%
|
(298)
N/A
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
(27)
N/A
|
2
N/A
|
(9)
N/A
|
(61)
-600%
|
(101)
-67%
|
(50)
+50%
|
2
N/A
|
7
+290%
|
13
+76%
|
(3)
N/A
|
(23)
-660%
|
(73)
-212%
|
|
Switch to:
Switch to:
See Also
Discover More
